Senator Bernie Sanders plans to grill the CEO of Moderna about his reported plans to raise the price of the coronavirus vaccine in a Senate hearing next month that he hopes will convince the company to reverse course, The Washington Post’s Liz Goodwin reports. The hearing will make up a key piece of Sander’s larger oversight agenda for the Health, Education, Labor and Pensions Committee that he chairs. Reference Link
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on MRNA:
- Model N price target raised to $52 from $45 at Truist
- Catalent price target raised to $82 from $75 at Baird
- Personalis upgraded to Buy at Needham on cost reductions, biopharma potential
- Personalis, Moderna announce new agreement to leverage NeXT Platform
- Novavax refuses to refund $700M for COVID shots never delivered, NY Times says